Advertisement
Screener

INSMED INC (INSM) Pre-Tax Margin

INSMED Inc Pre-Tax Margin

Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • INSMED Inc pre-tax margin for the quarter ending 2026-06-30 was -2.67%, a change of 295.65% year-over-year.
  • INSMED Inc pre-tax margin for the quarter ending 2026-03-31 was -52.98%, a change of 222.46% year-over-year.
  • INSMED Inc pre-tax margin for the quarter ending 2025-12-31 was -123.91%, a change of 100.41% year-over-year.
  • INSMED Inc pre-tax margin for the quarter ending 2025-09-30 was -259.02%, a change of -24.07% year-over-year.
  • INSMED Inc pre-tax margin for fiscal 2025 was -209.71%, a change of 40.51% from fiscal 2024.
  • INSMED Inc pre-tax margin for fiscal 2024 was -250.22%, a change of -5.46% from fiscal 2023.
  • INSMED Inc pre-tax margin for fiscal 2023 was -244.76%, a change of -49.06% from fiscal 2022.
  • INSMED Inc pre-tax margin for fiscal 2022 was -195.69%, a change of 35.87% from fiscal 2021.
Available history
2009-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2026-06-30-2.67%-$11.37M$425.49M
2026-03-31-52.98%-$162.1M$305.96M
2025-12-31-123.91%-$326.93M$263.84M
2025-09-30-259.02%-$368.7M$142.34M
2025-06-30-298.32%-$320.44M$107.42M
2025-03-31-275.44%-$255.67M$92.82M
2024-12-31-224.32%-$234.28M$104.44M
2024-09-30-234.96%-$219.51M$93.43M
2024-06-30-331.83%-$299.77M$90.34M
2024-03-31-207.29%-$156.5M$75.5M
2023-12-31-221.12%-$185.06M$83.69M
2023-09-30-200.31%-$158.39M$79.07M
2023-06-30-316.30%-$244.28M$77.23M
2023-03-31-244.24%-$159.28M$65.21M
2022-12-31-269.81%-$160M$59.3M
2022-09-30-193.08%-$130.77M$67.73M
2022-06-30-145.88%-$95.14M$65.22M
2022-03-31-177.45%-$94.24M$53.11M
2021-12-31-201.37%-$113.02M$56.12M
2021-09-30-246.58%-$115.29M$46.76M
2021-06-30-257.24%-$116.7M$45.37M
2021-03-31-227.29%-$91.4M$40.21M
2020-12-31-245.30%-$101.59M$41.42M
2020-09-30-145.14%-$63.34M$43.64M
2020-06-30-144.55%-$61.43M$42.5M
2020-03-31-179.95%-$66.33M$36.86M
2019-12-31-115.22%-$52.66M$45.71M
2019-09-30-155.67%-$60.53M$38.89M
2019-06-30-221.62%-$66.42M$29.97M
2019-03-31-337.59%-$73.94M$21.9M
2018-12-31-930.41%-$91.51M$9.84M
2013-06-30-76.99%-$8.85M$11.5M
2011-12-31-581.90%-$8.16M$1.4M
2011-09-30-7951.95%-$34.59M$435,000.00
2011-06-30-1024.23%-$10.02M$978,000.00
2011-03-31-430.48%-$6.89M$1.6M
2010-12-31-442.54%-$5.85M$1.32M
2010-09-30-14.00%-$253,000.00$1.81M
2010-06-30-20.12%-$375,000.00$1.86M

Annual Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2025-12-31-209.71%-$1.27B$606.42M
2024-12-31-250.22%-$910.07M$363.71M
2023-12-31-244.76%-$747.01M$305.21M
2022-12-31-195.69%-$480.15M$245.36M
2021-12-31-231.57%-$436.41M$188.46M
2020-12-31-178.02%-$292.69M$164.41M
2019-12-31-185.80%-$253.56M$136.47M
2018-12-31-3295.13%-$324.08M$9.84M
2013-12-31-498.21%-$57.29M$11.5M
2011-12-31-1350.78%-$59.66M$4.42M
2010-12-31-91.84%-$6.36M$6.92M
2009-12-311145.54%$118.83M$10.37M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Zoetis Inc. (ZTS)United States$29.045B11.38
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10